Trial intelligence / Profile preview

Strontium ranelate for delayed union or non-union of long bone fractures in osteoporotic adults

ISRCTN60251236Phase 3Completed

Sponsor
Servier
Start
Jun 2010
Modality
Small Molecules
01

Overview

Phase 3, single-arm trial of strontium ranelate in osteoporosis, fracture nonunion and delayed bone healing, sponsored by Servier. Primary endpoints: Radiological union of the fracture, Clinical assessments and 1 more. Started Jun 2010; status: completed.

02

Drugs

strontium ranelate
03

Conditions

osteoporosisfracture nonuniondelayed bone healing

Beyond the preview

Go deeper on ISRCTN60251236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN60251236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call